Cargando…

Effects of levosimendan in acute heart failure, cardiogenic and septic shock

Detalles Bibliográficos
Autores principales:	Alhashemi, JA, Alotaibi, Q
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088638/ http://dx.doi.org/10.1186/cc6488

Ejemplares similares

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Levosimendan in patients with acute cardiogenic shock, not responders to conventional therapy
por: Vetrugno, L, et al.
Publicado: (2007)

Hemodynamic and echographic effects of levosimendan in patients with cardiogenic shock refractory to catecholamines
por: Labbene, I, et al.
Publicado: (2006)

Effects of levosimendan and inhaled nitric oxide on microcirculation in septic shock
por: Morelli, A, et al.
Publicado: (2009)

Levosimendan therapy does not improve survival of post-resuscitation cardiogenic shock patients
por: Soos, P, et al.
Publicado: (2009)

Effects of levosimendan on renal function in septic shock: a case–control study
por: Morelli, A, et al.
Publicado: (2009)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Effects of levosimendan on cellular metabolic alterations in patients with septic shock: a randomised controlled study
por: Meddeb, B, et al.
Publicado: (2015)

Hemodynamic effects of levosimendan in patients with low-output heart failure
por: Gharsallah, H, et al.
Publicado: (2008)

Levosimendan in trauma patients with acute cardiac failure
por: Afonin, AN, et al.
Publicado: (2011)

Retrospective study of proarrhythmic effects of levosimendan during the therapy of heart failure
por: Zima, E, et al.
Publicado: (2007)

The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
por: Michalopoulou, H, et al.
Publicado: (2007)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

Combined effects of ivabradine with dobutamine or levosimendan in isolated perfused hearts
por: Konrad, D, et al.
Publicado: (2013)

Preoperative treatment with levosimendan helps to evaluate myocardial reserves in cardiosurgical patients with chronic heart failure
por: Eremenko, A, et al.
Publicado: (2015)

Cardiogenic shock: an experimental animal model
por: Tanamati, C, et al.
Publicado: (2005)

Heart rate reduction with esmolol in septic shock: effects on microcirculation
por: Morelli, A, et al.
Publicado: (2012)

Monitoring of cardiac output in cardiogenic shock and low-output heart failure: LiDCO vs pulmonary artery catheter thermodilution
por: Meyer, B, et al.
Publicado: (2006)

The PAPIKAS trial: a comparative clinical trial of pulmonary catheter versus the PiCCO device during therapy of patients with acute heart failure and cardiogenic shock
por: Schwab, T, et al.
Publicado: (2010)

Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
por: Garratt, C, et al.
Publicado: (2004)

Heart rate variability in the early resuscitation of septic shock
por: Arnold, RC, et al.
Publicado: (2009)

Heart rate reduction with esmolol in septic shock: effects on myocardial performance
por: Morelli, A, et al.
Publicado: (2014)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Long-term outcome after angioplasty in cardiogenic shock
por: Bulpa, P, et al.
Publicado: (2004)

Cardiogenic shock in the Aachen Digital Myocardial Infarction Registry
por: Kersten, A, et al.
Publicado: (2007)

Addition of levosimendan to overcome acute cardiogenic shock—Paving the way for later heart transplantation—A first case report
por: Flottmann, Christian, et al.
Publicado: (2020)

Influence of temperature on the cardiac action of dobutamine and levosimendan in isolated perfused hearts
por: Aldenhoff, U, et al.
Publicado: (2013)

Role of early continuous venovenous hemodiafiltration in septic shock and multiorgan failure
por: Soliman, M, et al.
Publicado: (2010)

Effect of transfusion, leukocyte-depleted blood product on onset of new septic shock and mortality in septic shock
por: Hayami, H, et al.
Publicado: (2010)

Haemodynamic effects of levosimendan following cardiac surgery
por: Slezina, A, et al.
Publicado: (2009)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006)

Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients
por: Grossini, Elena, et al.
Publicado: (2020)

Copeptin is a strong and independent predictor of outcome in cardiogenic shock
por: Meyer, B, et al.
Publicado: (2009)

BNP and NT-proBNP in patients with acute myocardial infarction complicated by cardiogenic shock: results from the IABP Shock trial
por: Lemm, H, et al.
Publicado: (2010)

Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
por: Guilherme, Enrique, et al.
Publicado: (2020)

Prognostic factors of septic shock
por: Quenot, JP, et al.
Publicado: (2012)

Fluid responsiveness in septic shock
por: Righetti, F, et al.
Publicado: (2014)

Homocysteine levels in septic shock
por: Mateu Campos, L, et al.
Publicado: (2015)

Cytokine levels is septic shock
por: Mateu Campos, L, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cf9n03rejesc9sp177jdqe8ooi